Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New heart valve implanted for first time | Key takeaways from ASE 2023 | TAVR vs. surgery | More from the last week
Saturday, July 8, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA approves world’s first dual-chamber leadless pacemaker system

The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium. 

READ MORE >
FDA approves Abbott’s Aveir dual chamber (DR) leadless pacemaker system, the world’s very first dual chamber leadless pacing solution for treating patients with abnormal heart rhythms.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves world’s first dual-chamber leadless pacemaker system

Share on Twitter Share on Facebook Share on Linkedin
FDA approves Abbott’s Aveir dual chamber (DR) leadless pacemaker system, the world’s very first dual chamber leadless pacing solution for treating patients with abnormal heart rhythms.
The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium. 
READ MORE >

AI model outperforms researchers’ ‘wildest dreams’ with accurate heart attack assessments

The algorithm, developed using data from more than 7,00 chest pain patients, performed better than multiple techniques currently used to evaluate cardiac events. 

READ MORE >
AI artificial intelligence stethoscope doctor
Share on Twitter Share on Facebook Share on Linkedin

AI model outperforms researchers’ ‘wildest dreams’ with accurate heart attack assessments

Share on Twitter Share on Facebook Share on Linkedin
AI artificial intelligence stethoscope doctor
The algorithm, developed using data from more than 7,00 chest pain patients, performed better than multiple techniques currently used to evaluate cardiac events. 
READ MORE >

New polymeric heart valve, designed to grow with pediatric patients, implanted for first time

The new-look pulmonary valve features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries.

READ MORE >
MASA Valve PECA Labs polymeric pulmonary valve Children’s Hospital of Philadelphia. The MASA Valve is a polymeric pulmonary valve designed and manufactured by Pennsylvania-based PECA Labs. It features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries. While the MASA Valve is not yet fully approved by the U.S. Food and Drug Administration (FDA), it has received the agency’s humanitarian use device and investigation device exemptions.
Share on Twitter Share on Facebook Share on Linkedin

New polymeric heart valve, designed to grow with pediatric patients, implanted for first time

Share on Twitter Share on Facebook Share on Linkedin
MASA Valve PECA Labs polymeric pulmonary valve Children’s Hospital of Philadelphia. The MASA Valve is a polymeric pulmonary valve designed and manufactured by Pennsylvania-based PECA Labs. It features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries. While the MASA Valve is not yet fully approved by the U.S. Food and Drug Administration (FDA), it has received the agency’s humanitarian use device and investigation device exemptions.
The new-look pulmonary valve features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries.
READ MORE >

Echo labs not using AI will be left behind

Echocardiography expert Roberto Lang, MD, says artificial intelligence will be so important to cardiac ultrasound in the near future that echo labs not using it will be inefficient and less accurate than labs that do use it.

READ MORE >
Roberto Lang, MD, explained the AI advances in echocardiography that will make it a requirement to have in the coming years at ASE 2023. #ASE #AIhealthcare #ASE2023
Share on Twitter Share on Facebook Share on Linkedin

Echo labs not using AI will be left behind

Share on Twitter Share on Facebook Share on Linkedin
Roberto Lang, MD, explained the AI advances in echocardiography that will make it a requirement to have in the coming years at ASE 2023. #ASE #AIhealthcare #ASE2023
Echocardiography expert Roberto Lang, MD, says artificial intelligence will be so important to cardiac ultrasound in the near future that echo labs not using it will be inefficient and less accurate than labs that do use it.
READ MORE >

Key takeaways in cardiac ultrasound from ASE 2023

James Kirkpatrick, MD, discussed some of the biggest trends and themes he saw at the American Society of Echocardiography's 2023 annual meeting.

READ MORE >
James Kirkpatrick, MD, explains the key trends at ASE 2023. #ASE23 #ASE2023
Share on Twitter Share on Facebook Share on Linkedin

Key takeaways in cardiac ultrasound from ASE 2023

Share on Twitter Share on Facebook Share on Linkedin
James Kirkpatrick, MD, explains the key trends at ASE 2023. #ASE23 #ASE2023
James Kirkpatrick, MD, discussed some of the biggest trends and themes he saw at the American Society of Echocardiography's 2023 annual meeting.
READ MORE >

TAVR vs. surgery: Exploring 5-year outcomes among intermediate-risk patients

A group of renowned TAVR specialists examined data from 783 pairs of intermediate-risk patients, sharing their findings in the Journal of the American College of Cardiology.

READ MORE >
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
Share on Twitter Share on Facebook Share on Linkedin

TAVR vs. surgery: Exploring 5-year outcomes among intermediate-risk patients

Share on Twitter Share on Facebook Share on Linkedin
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
A group of renowned TAVR specialists examined data from 783 pairs of intermediate-risk patients, sharing their findings in the Journal of the American College of Cardiology.
READ MORE >

Cardiology societies say affirmative action ruling will do long-term damage to patient care

The American College of Cardiology, Association of Black Cardiologists and several other U.S. societies released a new joint statement on the ruling.

READ MORE >
Supreme Court
Share on Twitter Share on Facebook Share on Linkedin

Cardiology societies say affirmative action ruling will do long-term damage to patient care

Share on Twitter Share on Facebook Share on Linkedin
Supreme Court
The American College of Cardiology, Association of Black Cardiologists and several other U.S. societies released a new joint statement on the ruling.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup